Pulmonary Fibrosis Learning and Self-Management Program (FILIP) for patients in rehab and outpatient care
Official title: Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study
Run by Insel Gruppe AG, University Hospital Bern · NCT07457463 · Data updated 2026-11-12
This study will try a blended digital education and self-management program for adults with fibrotic interstitial lung disease during pulmonary rehabilitation and outpatient ILD care to see if patients find it acceptable, practical, and linked to changes in health outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 2 sites (Bern and 1 other locations) |
| Status | Recruiting |
| Started | October 7, 2025 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | March 9, 2026 |
| Trial ID | NCT07457463 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with fibrotic interstitial lung disease who are able to consent, speak German, and are receiving inpatient pulmonary rehabilitation or outpatient ILD care at the participating centers are ideal candidates.
✕Probably not a fit
Patients with cognitive impairment, insufficient German language skills, sarcoidosis (which is excluded), or those not treated at the participating centers are unlikely to benefit from participating in this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, before-after observational cohort study implements a blended digital education and self-management program combining web-based e-learning modules with opportunities to discuss content with clinicians during routine inpatient pulmonary rehabilitation or outpatient ILD visits. A feasibility cohort receiving the program is compared to a historical control cohort treated before implementation, and an embedded feasibility sub-study examines recruitment, retention, and data collection processes. Outcomes include measures of acceptability, usability, and selected health-related outcomes collected before and after program use. The study focuses on adults with fibrotic interstitial lung disease treated at participating centers in Bern, Switzerland.
Why it matters
Potential benefit: If successful, the program could improve patients' disease knowledge, self-management skills, symptom coping, and overall quality of life.
How similar studies have gone: Similar digital and blended self-management programs have shown benefits in other chronic respiratory diseases like COPD, but evidence specifically in fibrotic ILD is limited and this approach remains relatively novel for this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria are: * Diagnosis of a FILD as major indication for pulmonary rehabilitation (for Berner Reha Zentrum only) * Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose (for Inselspital only) * Age ≥ 18 years * Written informed consent Exclusion criteria are: * Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures * Sarcoidosis
Where it's running
-
Center for Rehabilitation & Sports Medicine Inselspital and Berner Reha Zentrum, Bern University Hospital, University of Bern, Switzerland
Heiligenschwendi, Switzerland Recruiting -
Department for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
Bern, Switzerland Not yet recruiting
Study contacts
- Principal investigator: Thimo Marcin, PHD — Center for Rehabilitation & Sports Medicine Inselspital and Berner Reha Zentrum, Bern University Hospital, University of Bern, Switzerland
- Study coordinator: Thimo Marcin, PhD
- Email: thimo.marcin@rehabern.ch
- Phone: +41 33 244 3048
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote monitoring to see if home spirometry, oximetry, scales, and surveys help track ILD
This study tests whether a combination of home monitoring devices and electronic surveys can be used effectively to detect meaningful changes in health for adults with fibrotic interstitial lung disease.
-
Evaluating inhalable Imatinib for treating pulmonary hypertension and lung fibrosis
This study is testing a new inhalable medication called XHALIP to see if it can help people with pulmonary hypertension and lung fibrosis feel better by improving their lung health.
-
Understanding hemorrhage subtypes in perimesencephalic SAH and basilar artery perforator aneurysms
This study tests whether different bleeding patterns in pmSAH, including potential basilar artery perforator aneurysms, relate to patient outcomes using a patient-reported EQ-5D measure.
-
Pediatric Outpatient Health Data Cohort in Switzerland
This study tests the PROS-CH data-collection system in pediatric primary care to see if routine tools can build a useful cohort of children under age 2 for common health issues.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
Left vs right subthalamic nucleus deep brain stimulation: how it changes thinking and mood in Parkinson’s
This study tests whether turning DBS on the left or the right side of the brain changes cognition and mood in people with Parkinson’s disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.